The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Anaplasma phagocytophilum

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Anaplasma phagocytophilum

 

High impact information on Anaplasma phagocytophilum

  • These findings showed that p44 multigenes have several active expression sites and the expression is regulated at transcriptional level, suggesting a potentially unique mechanism for generating the diversity in major antigenic outer membrane proteins of the HGE agent [6].
  • We previously cloned a gene encoding HGE agent 44-kDa major outer membrane protein and designated it p44 [6].
  • The present study provides new information for understanding the role of the p44 multigene family in transmission of the HGE agent between mammals and ticks [7].
  • Among PBLs, neutrophils and lymphocytes expressed IL-1beta mRNA but not TNF-alpha or IL-6 mRNA in response to the HGE agent, whereas monocytes expressed all three of these cytokine mRNAs [8].
  • Expression of IL-8, IL-10, gamma interferon, transforming growth factor beta, and IL-2 mRNAs in response to the HGE agent was not remarkable [8].
 

Chemical compound and disease context of Anaplasma phagocytophilum

 

Biological context of Anaplasma phagocytophilum

 

Anatomical context of Anaplasma phagocytophilum

 

Gene context of Anaplasma phagocytophilum

  • These data demonstrate that the HGE agent elicits a prominent IFN-gamma response in mice and that IFN-gamma is important in controlling the degree of rickettsemia during the early phase of infection, while IFN-gamma independent mechanisms play a role at later time points [14].
  • However, HGE agent infection had no effect on IRP-1 binding activity [4].
  • The percent identities of the gltA nucleotide sequences among ehrlichial species were 49.7% (E. risticii versus A. centrale) to 99.8% (HGE agent versus E. equi) [15].
  • Sera were obtained from 18 patients with HGE, mostly within the first 6 weeks of clinical infection, and from mice infected with the HGE agent for up to 3 weeks [16].
  • Of the seropositive patients, HGE agent DNA was detected by polymerase chain reaction in the first serum from 4 of 5 patients and was present in the serum of 1 of 2 untreated patients after 21 days, even when E. equi antibodies also were present [17].
 

Analytical, diagnostic and therapeutic context of Anaplasma phagocytophilum

  • Western blot results with the OMP fraction of the six isolates were consistent with results with the whole HGE agent [18].
  • Previous serologic studies in patients with a diagnosis of Lyme borreliosis indicate that HGE may exist in Europe. We report the first documented case of HGE in Europe. The diagnosis was established by seroconversion to E. equi and the HGE agent and by PCR with sequence analysis of the gene encoding the HGE agent 16S rRNA [19].

References

  1. Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. Rikihisa, Y., Zhi, N., Wormser, G.P., Wen, B., Horowitz, H.W., Hechemy, K.E. J. Infect. Dis. (1997) [Pubmed]
  2. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Klein, M.B., Nelson, C.M., Goodman, J.L. Antimicrob. Agents Chemother. (1997) [Pubmed]
  3. ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Caturegli, P., Asanovich, K.M., Walls, J.J., Bakken, J.S., Madigan, J.E., Popov, V.L., Dumler, J.S. Infect. Immun. (2000) [Pubmed]
  4. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Barnewall, R.E., Ohashi, N., Rikihisa, Y. Infect. Immun. (1999) [Pubmed]
  5. Production of tumour necrosis factor-alpha (TNF-alpha) and reactive nitrogen intermediates by ovine peripheral blood leucocytes stimulated by Ehrlichia (Cytoecetes) phagocytophila. Gokce, H.I., Woldehiwet, Z. J. Comp. Pathol. (2002) [Pubmed]
  6. Multiple p44 genes encoding major outer membrane proteins are expressed in the human granulocytic ehrlichiosis agent. Zhi, N., Ohashi, N., Rikihisa, Y. J. Biol. Chem. (1999) [Pubmed]
  7. Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. Zhi, N., Ohashi, N., Tajima, T., Mott, J., Stich, R.W., Grover, D., Telford, S.R., Lin, Q., Rikihisa, Y. Infect. Immun. (2002) [Pubmed]
  8. Expression of interleukin-1beta, tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44. Kim, H.Y., Rikihisa, Y. Infect. Immun. (2000) [Pubmed]
  9. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Yoshiie, K., Kim, H.Y., Mott, J., Rikihisa, Y. Infect. Immun. (2000) [Pubmed]
  10. Prophylactic use of long-acting tetracycline against tick-borne fever (Cytoecetes phagocytophila) in sheep. Brodie, T.A., Holmes, P.H., Urquhart, G.M. Vet. Rec. (1988) [Pubmed]
  11. Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus). Ravyn, M.D., Kodner, C.B., Carter, S.E., Jarnefeld, J.L., Johnson, R.C. J. Clin. Microbiol. (2001) [Pubmed]
  12. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. Zhi, N., Ohashi, N., Rikihisa, Y., Horowitz, H.W., Wormser, G.P., Hechemy, K. J. Clin. Microbiol. (1998) [Pubmed]
  13. Prevalence of the agent of human granulocytic ehrlichiosis in Ixodes scapularis (Acari: Ixodidae) in the coastal southeastern United States. Fang, Q.Q., Mixson, T.R., Hughes, M., Dunham, B., Sapp, J. J. Med. Entomol. (2002) [Pubmed]
  14. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Akkoyunlu, M., Fikrig, E. Infect. Immun. (2000) [Pubmed]
  15. Citrate synthase gene sequence: a new tool for phylogenetic analysis and identification of Ehrlichia. Inokuma, H., Brouqui, P., Drancourt, M., Raoult, D. J. Clin. Microbiol. (2001) [Pubmed]
  16. The early humoral response in human granulocytic ehrlichiosis. IJdo, J.W., Zhang, Y., Hodzic, E., Magnarelli, L.A., Wilson, M.L., Telford, S.R., Barthold, S.W., Fikrig, E. J. Infect. Dis. (1997) [Pubmed]
  17. Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. Dumler, J.S., Bakken, J.S. J. Infect. Dis. (1996) [Pubmed]
  18. Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent. Kim, H.Y., Rikihisa, Y. J. Clin. Microbiol. (1998) [Pubmed]
  19. Human disease in Europe caused by a granulocytic Ehrlichia species. Petrovec, M., Lotric Furlan, S., Zupanc, T.A., Strle, F., Brouqui, P., Roux, V., Dumler, J.S. J. Clin. Microbiol. (1997) [Pubmed]
 
WikiGenes - Universities